How Much Is Tarqvara Pharma Technologies OÜ Worth?
Tarqvara Pharma Technologies OÜ - Company Valuation
Combines filings, registry risk signals, and versioned market evidence. Learn More ↗ Opens in a New Tab
Enterprise Value
76,010 €
- Range
- 53,033 €–136,351 €
- Evidence StrengthShows how strongly available evidence supports the result. Learn More ↗ Opens in a New Tab
- Low
- Based on FY
- 2025
- Valuation Date
- Business StrengthSummarises business strength from financial and public-record signals. Learn More ↗ Opens in a New Tab
- B
- Risks
- Insufficient Data
Scope & Evidence
- Company
- Tarqvara Pharma Technologies OÜ
- Registration
- EE · 14737721
- Covers
- Single Company
- Filings Used
- 7 · FY 2025, 2024, 2023, 2022, 2021, 2020, 2019
Industry: NACE 71 · 1 Emerging Markets industry cohort
Methodology & Assumptions
- Industry EV / EBITDA
- 10.8×
- Industry Revenue Multiple
- 0.70×
- Revenue Multiple
- 0.70×
- Enterprise Value
- 76,010 €
- Value Before Discount
- 76,010 €
Key Ratios
- Current RatioCurrent assets divided by current liabilities. Learn More ↗ Opens in a New Tab
- 12.26×
- Quick RatioCurrent assets minus inventory, divided by current liabilities. Learn More ↗ Opens in a New Tab
- -
- Debt / EquityTotal liabilities divided by equity. Learn More ↗ Opens in a New Tab
- 0.09×
- Equity RatioEquity as a share of total assets. Learn More ↗ Opens in a New Tab
- 91.8%
- Interest CoverageEBIT divided by interest expense. Learn More ↗ Opens in a New Tab
- -
- Gross MarginGross profit as a share of revenue. Learn More ↗ Opens in a New Tab
- -
- Net Profit MarginNet profit as a share of revenue. Learn More ↗ Opens in a New Tab
- 32.4%
- Return on EquityNet profit as a share of owners' equity. Learn More ↗ Opens in a New Tab
- 54.0%
- Return on AssetsNet profit as a share of total assets. Learn More ↗ Opens in a New Tab
- 49.6%
- Revenue CAGRAverage annual revenue growth over the available period. Learn More ↗ Opens in a New Tab
- 23.1%
Liability Maturity
Short-Term
3-Year Revenue Scenarios
280k €
210k €
140k €
70k €
0 €
202620272028
OptimisticBaseConservative
A comparison between a company and a defined peer group. Learn More ↗ Opens in a New Tab
Revenue vs Industry Peers
- Repligen Estonia OÜ
- 14,651,711 €
- AS Infragate Eesti
- 9,068,893 €
- TARTS OÜ
- 256,861 €
- Tarqvara Pharma Technologies OÜ ★
- 105,949 €
- Tartu Geodeesia OÜ
- 46,840 €
- Tartu Eke Projekt OÜ
- 20,242 €
Earnings before interest, taxes, depreciation, and amortisation. Learn More ↗ Opens in a New Tab
Revenue, Profit & EBITDA
140k €
105k €
70k €
35k €
0 €
20212022202320242025
RevenueNet Profit
Versus Industry Median
120k €
90k €
60k €
30k €
0 €
RevenueNet Profit
This CompanyIndustry Median